Location of the Median Nerve in Carpal Tunnel Spasticity in Patients with Hemiplegic Cerebral Palsy

Institutional Review Board, Hospital for Special Surgery

The safety of study participants is our top priority. The trial is approved and periodically reviewed by an Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.

Before enrolling in a clinical trial, the investigator will explain the purpose of the trial, its expected benefits, any possible risks or side effects, and what your role will be. This is the time to ask questions! If you want to join the trial, you must sign the informed consent documents. You can leave a clinical trial at any time without penalty.

For further information, see Understanding Clinical Trials.

Principal Investigator

Michelle G. Carlson, MD

Co-Investigators

 

Thedore T. Miller, MD, FACR
Gregory R. Saboeiro, MD
Lorene Janowski, Occupational Therapist
Tracy Klein

 

 

Summary

This research is an observational study on the median nerve positioning in the affected hand/arm of people with hemiplegic cerebral palsy to see if it differs from the general population. Fifteen patients will be enrolled, beginning in 2010.  Patients will undergo an ultrasound on the affected arm.  For patients with typical positioning of the median nerve, there is no follow-up.  For other patients, follow-up is undetermined.

Inclusion/Exclusion Criteria

Inclusion Criteria:

·        Diagnosis of hemiplegic Cerebral Palsy with flexor tendon spasticity

·        Patient of the principal investigator

·        Age 2 years and older

·        Able to understand the informed consent and sign consent/assent for themselves

Exclusion Criteria

·        Prior surgeries on affected arm

·        Patients who are unable to understand the informed consent and sign the consent/assent for themselves

Contact Information

Tracy Klein
KleinT@hss.edu
212.774.2727